Altered inotropic reactivity in diabetic rabbit right ventricular myocardium

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 10, 2004, Pages 903-910

  Rex Lee, J ^a   Zhang, Xin Jian ^a   Lin, Bor Kang ^a   Reigel, Charles E ^b   Tenner Jr , Thomas E ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

adrenoceptor density; Calcium utilization; Experimental diabetes; Hyperresponsiveness; Inotropic state; Subsensitivity

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ALLOXAN; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CATECHOLAMINE; FORSKOLIN; INSULIN; ISOPRENALINE; L 858051; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM UTILIZATION; CARDIOVASCULAR RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG SENSITIVITY; HEART MUSCLE; HEART MUSCLE CONTRACTILE FORCE; HEART RIGHT VENTRICLE; INOTROPISM; INSULIN TREATMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR DENSITY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; CALCIUM SIGNALING; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN BINDING; RABBITS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 13544264558     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-101     Document Type: Conference Paper

References (30)

1. Alipui, C., Ramos, K., and Tenner, T.E., Jr. 1993. Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus. Cardiovasc. Res. 27: 1229-1232.
2. Bell, R.H., Jr., and Hye, R.J. 1983. Animals models of diabetes mellitus: physiology and pathology. J. Surg. Res. 35: 433-460.
3. Bodem, R., and Sonnenblick, E.H. 1975. Mechanical activity of mammalian heart muscle: variable onset, species differences, and the effect of caffeine. Am. J. Physiol. 228: 250-261.
4. Brown, L., Deighton, N.M., Bals, S., Sohlmann, W., Zerkowski, H.R., Michel, M.C., and Brodde, O.E. 1992. Spare receptors for β-adrenoceptor- mediated positive inotropic effects of catecholamines in the human heart. J. Cardiovasc. Pharmacol. 19: 222-232.
5. Clark, R.J., McDonough, P.M., Swanson, E., Trost, S.U., Suzuki, M., Fukuda, M., and Dillmann, W.H. 2003. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278 (45): 44 230-44 237.
6. Fabiato, A., and Fabiato, F. 1978. Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and new-born rat ventricles. Ann. N.Y. Acad. Sci. 307: 491-522.
7. Fein, F.S., Miller-Green, B., and Sonnenblick, E.H. 1985. Altered myocardial mechanics in diabetic rabbits. Am. J. Physiol. 248: H729-H736.
8. Felice, L.J., Felice, J.D., and Kissinger, P.T. 1978. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 31: 1461-1465.
9. Fleming, W.W., Westfall, D.P., De La Lande, I.S., and Jehlett, L.B. 1972. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181: 339-245.
10. Galderisi, M.G., Anderson, K.M., Wilson, P.W.F., and Levy, D. 1991. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham heart study). Am. J. Cardiol. 68: 85-89.
11. Ganguly, P.K., Pierce, G.N., Dhalla, K.S., and Dhalla, N.S. 1983. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am. J. Physiol. 244: E528-E535.
12. Garcia, M.J., McNamara, P.M., Gordon, T., and Kannel, W.B. 1974. Morbidity and mortality in diabetics in the Framingham population sixteen year follow-up study. Diabetes, 23: 105-111.
13. Gunasekaran, S., Young, J.A., and Tenner, T.E., Jr. 1993. Pharmacological study of isoproterenol and diabetic cardiomyopathies in rat right ventricular strips. Pharmacology, 46: 101-108.
14. Jackson, C.V., Mcgrath, G.M., Tahliani, A.G., Vadlamudi, R.V.S.V., and McNeill, J.H. 1985. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Diabetes, 34: 876-883.
15. Kannel, W.P., and McGee, D.L. 1979. Diabetes and cardiovascular disease: the Framingham heart study. JAMA (J. Am. Med. Assoc.), 241: 2035-2038.
16. Kannel, W.B., Hjortland, M., and Castelli, W.P. 1974. Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34: 29-34.
17. Lee, J.R., Zhang, X.-J., and Tenner, T.E., Jr. 1999. Evidence of spare beta-adrenoceptors in the rabbit heart. Proc. West. Pharmacol. Soc. 42: 41-44.
18. Lompre, A.M., Mercadier, J.J., Wisnewsky, C., Bouveret, P., Pantaloni, C., D'Albis, A., and Schwartz, K. 1981. Species and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84: 286-290.
19. Lopaschuk, G.D., Katz, S., and McNeill, J.H. 1983. The effect of alloxan-induced and streptozotocin-induced diabetes on calcium transport in the rat cardiac sarcoplasmic reticulum - the possible involvement of long-chain acylcarnitines. Can. J. Physiol. Pharmacol. 61: 439-448.
20. McPherson, G.A. 1985. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods, 14: 213-228.
21. Mengi, S.A., and Dhalla, N.S. 2004 Carnitine palmitoyltransferase-I, a new target for the treatment of heart failure: perspectives on a shift in myocardial metabolism as a therapeutic intervention. Am. J. Cardiovasc. Drugs, 4: 201-209.
22. Mukherjee, C., Caron, M.G., and Lefkowitz, R.J. 1975. Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of β-adrenergic receptor binding sites. Proc. Natl. Acad. Sci. 72: 1945-1949.
23. Munson, P.J., and Rodbard, D. 1980. A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107: 220-239.
24. Penpargkul, S., Fein, F., Sonnenblick, E.H., and Scheuer, J. 1981. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J. Mol. Cell. Cardiol. 13: 303-309.
25. Ramanadham, S., and Tenner, T.E., Jr. 1983. Alterations in cardiac performance in experimentally-induced diabetes. Pharmacology, 27: 130-139.
26. Ramanadham, S., and Tenner, T.E., Jr. 1987. Alterations in the myocardial β-adrenoceptor system of streptozotocin-diabetic rats. Eur. J. Pharmacol. 136: 377-389.
27. Ramanadham, S., Young, J., and Tenner, T.E., Jr. 1987. Prevention of strepto-zotocin-induced alterations in the rat heart by 3-O-methyl glucose and insulin treatments. J. Cardiovasc. Pharmacol. 9: 291-297.
28. Sen, L., O'Neill, M., Marsh, J.D., and Smith, T.W. 1990. Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters. Circ. Res. 67: 599-608.
29. Tenner, T.E., Jr., Young, J.A., Earley, K.J., and Yen, Y.C. 1989. Functional characterization of β-adrenoceptor subtypes in rabbit right atria. Life Sci. 44: 651-660.
30. 2+-ATPaSe improves myocardial contractility in diabetic cardiomyopathy. Diabetes, 51: 1166-1171.